Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Breast and nipple neoplasms malignant
ADR ID BADD_A00695
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.10      Breast neoplasms malignant and unspecified (incl nipple)
16.10.01      Breast and nipple neoplasms malignant
Description Not Available
MedDRA Code 10006290
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02170Testosterone0.000364%
BADD_D02174Testosterone undecanoate-
BADD_D02236Tofacitinib0.004822%
BADD_D02237Tofacitinib citrate--
BADD_D02246Tolvaptan--
BADD_D02252Tositumomab--
BADD_D02254Tramadol--
BADD_D02259Trandolapril--
BADD_D02299Trisequens--
BADD_D02312Ulipristal--
BADD_D02322Ustekinumab--
BADD_D02331Valsartan0.000899%
BADD_D02342Vedolizumab--
BADD_D02346Venlafaxine0.000097%
BADD_D02363Vinorelbine0.000358%
BADD_D02365Vismodegib0.000112%
BADD_D02375Water--
BADD_D02392Zoledronic acid0.029202%
BADD_D02393Zolmitriptan--
BADD_D02397Zopiclone--
BADD_D02407Upadacitinib0.003279%
BADD_D02412Octreotide--
BADD_D02442Magnesium oxide0.000182%
BADD_D02452Icatibant-
BADD_D02464Fingolimod0.036215%
BADD_D02473Sodium chloride0.000241%
BADD_D02483Ribociclib0.005675%
BADD_D02487Baricitinib0.000964%
BADD_D02489Neratinib0.000694%
BADD_D02498Abemaciclib0.001175%
The 6th Page    First    Pre   6 7    Next   Last    Total 7 Pages